AlbumiNZ™ Protease-reduced BSA
Description
Product Description
AlbumiNZ™ Protease-reduced BSA is chromatographically purified from New Zealand-sourced bovine plasma in an ISO quality system assuring complete traceability and consistent high quality. There is no detectable enzymatic activity.
Application Notes
AlbumiNZ™ Protease-reduced BSA is useful for immunoassays where proteases may degrade proteins or where peroxidase or alkaline phosphatase may hydrolyze substrates.
Usage Statement
Research Use Only (RUO). Ready for CE IVD labeling of clinical applications.
Key Applications
Immunoassay
Specifications
| SKU | 02199898-CF |
| Alternate Names | BSA; Bovine albumin; Bovine Plasma Albumin |
| Application Notes | AlbumiNZ™ Protease-reduced BSA is useful for immunoassays where proteases may degrade proteins or where peroxidase or alkaline phosphatase may hydrolyze substrates. |
| Biochemical Physiological Actions | Certain conformational and primary-sequence epitopes of BSA are suspected allergens in human beef and milk allergies. |
| Concentration | Total Protein ≥95% |
| EC Number | 232-936-2 |
| Foreign Activity | Protease Reduced |
| Grade | Protease Reduced, Grade |
| Applications | Immunoassay |
| MDL # | MFCD00130384 |
| Moisture Content | ≤5% |
| Personal Protective Equipment | Eyeshields, Gloves, Respirator filter |
| pH | 6.5 - 7.5(4% w/v soln) |
| Physical Appearance | Off-white to Light Yellowish to Brown Powder |
| Presentation | Off-white to Light Yellowish to Brown Powder |
| Product Families Description | AlbumiNZ™ Protease-reduced BSA is chromatographically purified from New Zealand-sourced bovine plasma in an ISO quality system assuring complete traceability and consistent high quality. There is no detectable enzymatic activity. |
| Purity | ≥97% w/w Total Protein |
| Recommended Replacement For | 0884103 |
| Solubility | Dissolves in ≤20 min at 20-25 °C (20% w/w in water). |
| Storage and Handling | Store at +4 °C. |
| Trade Name | AlbumiNZ™ |
| Usage Statement | Research Use Only (RUO). Ready for CE IVD labeling of clinical applications. |